Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 9,577-9,588 of 23,847
Behavioral study icon
CompletedNCT00431574

Antipsychotic Medication Extended Dosing Study

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.

In Toronto
SchizophreniaOtherFrom 18 Years to 75 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
Drug study icon
CompletedNCT00493233

Antipsychotic Polypharmacy in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Toronto
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 80 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
Drug study icon
CompletedNCT00018668

Antipsychotic Response in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In San Diego
SchizophreniaDrugFrom 21 Years to 70 Years
Countries
United States
Sponsor
US Department of Veterans Affairs
Condition
Schizophrenia
Drug study icon
CompletedNCT00334035

Antipsychotic Therapy and First Episode

This summary needs review. Please check the official study record and contact the research team for details.

In Hong Kong
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
China
Sponsor
The University of Hong Kong
Condition
Schizophrenia
Drug study icon
CompletedNCT00585273

Antipsychotics and Blood Vessel Function

This study exists to understand how smoking support or smoking-related treatment holds up over time after the earliest research stage. Researchers are trying to understand whether smoking support or smoking-related treatment can better support energy, concentration, and everyday functioning.

In Iowa City
Schizophrenia, BipolarityOtherFrom 18 Years to 50 Years
Countries
United States
Sponsor
Jess G. Fiedorowicz
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedNCT01185743

Antipsychotics and Gene Expression in Soft Tissues

This summary needs review. Please check the official study record and contact the research team for details.

In Vienna
SchizophreniaDrugFrom 18 Years to 45 Years
Countries
Austria
Sponsor
Medical University of Vienna
Condition
Schizophrenia
Drug study icon
CompletedNCT02582736

Antipsychotics and Risk of Hyperglycemic Emergencies

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can better prevent setbacks and support longer-term stability.

In Toronto
Schizophrenia, BipolarityDrugOver 18 Years
Countries
Canada
Sponsor
Canadian Network for Observational Drug Effect Studies, CNODES
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedNCT04724447

ANTIVIRAL TREATMENT OF CYTOMEGALOVIRUS IN DEPRESSION

This study is looking at care and outcomes for people with depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

In Tulsa
DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Laureate Institute for Brain Research, Inc.
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.